Skip to main content

Table 1 Patient characteristics and preoperative clinical factors

From: Outcomes of surgical resection for pulmonary metastasis from ovarian cancer

Pt Age Pathologic stage of ovarian cancer Pathology Treatment mode for the primary tumor Metastatic site other than lung before pulmonary resection Disease-free interval (months) Laterality Tumor number Tumor size (mm) FDG uptake (SUVmax) Lymph node involvement
1 64 I clear cell adenocarcinoma S none 26 unilateral 1 23 8 no
2 72 IV serous papillary cystadenocarcinoma S none 188 unilateral 1 10 1.6 no
3 75 IV serous adenocarcinoma C + S + C none 10 unilateral 1 17 5.9 no
4 39 III undifferentiated carcinoma S + C none 31 unilateral 1 19 6.6 yes
5 44 IV undifferentiated carcinoma S + C liver 0 unilateral 1 18 5.8 no
6 72 III endometroid adenocarcinoma S none 18 unilateral 3 5 not done no
  1. C chemotherapy, FDG 2-deoxy-2- [fluorine-18] fluoro-D- glucose, SUVmax maximum standardized uptake value, S surgery